The International Association of Athletics Federations (IAAF) continues to be in the news recently regarding allegations of widespread doping and lowest cost viagra subsequent cover-ups. While reading all this coverage, it reminded me of an essay I wrote for my law Masters discussing the premise that doping (and, further in the future, genetic enhancement) was a natural progression of sport and therefore a positive thing. I’ve re-written and expanded on portions here to make it a little more readable. Let the caverta cheap cialis generic viagra debate commence!
Bleeding edge science often finds itself chasing a moving target. For example, in 1997, chess was seen as the epitome of human intelligence yet as soon Deep Blue beat Garry Kasparov, many were quick to extoll the differences between intuition and algorithms and the beauty of the mind’s expertise with the brute force of assessing 200 million chess moves a second. Just as Deep Blue generated discussions on the definitions of “true” intelligence, humanity and many peripheral philosophical discussions, the massive advances in pharmaceutical sciences and, more recently, genetic therapies have opened a similar frontier in athletics —with one key difference.
Artificial intelligence is just that: artificial. Doping and genetic therapies are about “improving” humans and buy lasix no prescription our own abilities to perform and push those boundaries. So while as a society, humans ordinarily embrace and celebrate our technological advances, recent years they have started to impinge on what it means to actually be human. However, ever since humans have competed in sporting and athletic events, they have tried all means available to them to achieve their best possible results.
As such, when Julian Savulescu, Professor of Practical Ethics at the University of Oxford, argued that “[g]enetic enhancement is not against the levitra cheapest best buy lowest cost spirit of sport; it is the spirit of sport” it was guaranteed to divide opinions. So, was he right? Continue reading “Chasing a Moving Target: Has Anti-Doping Failed?”